AbbVie reports Q3 adjusted EPS $1.86, consensus $1.78

Reports Q3 revenue $15.78B, consensus $15.58B. “AbbVie (ABBV) continues to deliver outstanding results, with significant momentum across key areas of our portfolio. We are also making great progress advancing our pipeline and investing in innovation to support AbbVie’s long-term growth,” said Robert Michael, chairman and chief executive officer, AbbVie. “Based upon the strength of our business and its promising outlook, we are once again raising our quarterly cash dividend.”